{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:14:58Z","timestamp":1789906498870,"version":"4.0.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T00:00:00Z","timestamp":1447804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T00:00:00Z","timestamp":1447804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Replication defective adenoviruses are promising vectors for the delivery of vaccine antigens. However, the potential of a vector to elicit transgene-specific adaptive immune responses is largely dependent on the viral serotype used. HAdV-5 (<jats:italic>Human adenovirus C<\/jats:italic>) vectors are more immunogenic than chimpanzee adenovirus vectors from species <jats:italic>Human adenovirus E<\/jats:italic> (ChAdOx1 and AdC68) in mice, though the mechanisms responsible for these differences in immunogenicity remain poorly understood. In this study, superior immunogenicity was associated with markedly higher levels of transgene expression <jats:italic>in vivo<\/jats:italic>, particularly within draining lymph nodes. To investigate the viral factors contributing to these phenotypes, we generated recombinant ChAdOx1 vectors by exchanging components of the viral capsid reported to be principally involved in cell entry with the corresponding sequences from HAdV-5. Remarkably, pseudotyping with the HAdV-5 fiber and\/or penton RGD loop had little to no effect on <jats:italic>in vivo<\/jats:italic> transgene expression or transgene-specific adaptive immune responses despite considerable species-specific sequence heterogeneity in these components. Our results suggest that mechanisms governing vector transduction after intramuscular administration in mice may be different from those described <jats:italic>in vitro<\/jats:italic>.<\/jats:p>","DOI":"10.1038\/srep16756","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T10:57:35Z","timestamp":1447844255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice"],"prefix":"10.1038","volume":"5","author":[{"given":"Matthew D. J.","family":"Dicks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra J.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolis","family":"Bauza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian V. S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew G.","family":"Cottingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,18]]},"reference":[{"key":"BFsrep16756_CR1","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","volume":"372","author":"SP Buchbinder","year":"2008","unstructured":"Buchbinder, S. P. et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372, 1881\u20131893 (2008).","journal-title":"Lancet"},{"key":"BFsrep16756_CR2","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","volume":"372","author":"MJ McElrath","year":"2008","unstructured":"McElrath, M. J. et al. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 372, 1894\u20131905 (2008).","journal-title":"Lancet"},{"key":"BFsrep16756_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1172\/JCI60202","volume":"122","author":"N Frahm","year":"2012","unstructured":"Frahm, N. et al. Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine. J Clin Invest 122, 359\u2013367 (2012).","journal-title":"J Clin Invest"},{"key":"BFsrep16756_CR4","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/infdis\/jir850","volume":"205","author":"GA O\u2019Hara","year":"2012","unstructured":"O\u2019Hara, G. A. et al. Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector. The Journal of infectious diseases 205, 772\u2013781 (2012).","journal-title":"The Journal of infectious diseases"},{"key":"BFsrep16756_CR5","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1038\/mt.2011.176","volume":"19","author":"SH Sheehy","year":"2011","unstructured":"Sheehy, S. H. et al. Phase Ia Clinical Evaluation of the Plasmodium falciparum Blood-stage Antigen MSP1 in ChAd63 and MVA Vaccine Vectors. Mol Ther 19, 2269\u20132276 (2011).","journal-title":"Mol Ther"},{"key":"BFsrep16756_CR6","doi-asserted-by":"publisher","first-page":"e31208","DOI":"10.1371\/journal.pone.0031208","volume":"7","author":"SH Sheehy","year":"2012","unstructured":"Sheehy, S. H. et al. Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors. PLoS One 7, e31208 (2012).","journal-title":"PLoS One"},{"key":"BFsrep16756_CR7","doi-asserted-by":"publisher","first-page":"115ra111","DOI":"10.1126\/scitranslmed.3003155","volume":"4","author":"E Barnes","year":"2012","unstructured":"Barnes, E. et al. Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man. Science translational medicine 4, 115ra111 (2012).","journal-title":"Science translational medicine"},{"key":"BFsrep16756_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/infdis\/jis670","volume":"207","author":"LR Baden","year":"2013","unstructured":"Baden, L. R. et al. First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001). The Journal of infectious diseases 207, 240\u2013247, (2013).","journal-title":"The Journal of infectious diseases"},{"key":"BFsrep16756_CR9","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1164\/rccm.200910-1484OC","volume":"181","author":"B Abel","year":"2010","unstructured":"Abel, B. et al. The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults. American journal of respiratory and critical care medicine 181, 1407\u20131417 (2010).","journal-title":"American journal of respiratory and critical care medicine"},{"key":"BFsrep16756_CR10","doi-asserted-by":"crossref","unstructured":"Rampling, T. et al. A Monovalent Chimpanzee Adenovirus Ebola Vaccine - Preliminary Report. N Engl J Med, doi:10.1056\/NEJMoa1411627 (2015).","DOI":"10.1056\/NEJMoa1411627"},{"key":"BFsrep16756_CR11","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1128\/JVI.02696-06","volume":"81","author":"P Abbink","year":"2007","unstructured":"Abbink, P. et al. Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J Virol 81, 4654\u20134663 (2007).","journal-title":"J Virol"},{"key":"BFsrep16756_CR12","doi-asserted-by":"publisher","first-page":"115ra112","DOI":"10.1126\/scitranslmed.3002925","volume":"4","author":"S Colloca","year":"2012","unstructured":"Colloca, S. et al. Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species. Science translational medicine 4, 115ra112 (2012).","journal-title":"Science translational medicine"},{"key":"BFsrep16756_CR13","doi-asserted-by":"publisher","first-page":"6109","DOI":"10.4049\/jimmunol.1103717","volume":"188","author":"MJ Johnson","year":"2012","unstructured":"Johnson, M. J. et al. Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicity. Journal of immunology 188, 6109\u20136118 (2012).","journal-title":"Journal of immunology"},{"key":"BFsrep16756_CR14","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.vaccine.2015.01.042","volume":"33","author":"MD Dicks","year":"2015","unstructured":"Dicks, M. D. et al. The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species. Vaccine, 33, 1121\u20131128 (2015).","journal-title":"Vaccine"},{"key":"BFsrep16756_CR15","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1172\/JCI78280","volume":"125","author":"KM Quinn","year":"2015","unstructured":"Quinn, K. M. et al. Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling. J Clin Invest, 125, 1129\u20131146 (2015).","journal-title":"J Clin Invest"},{"key":"BFsrep16756_CR16","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/mt.2013.284","volume":"22","author":"RD Antrobus","year":"2013","unstructured":"Antrobus, R. D. et al. Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens. Mol Ther 22, 668\u2013674 (2013).","journal-title":"Mol Ther"},{"key":"BFsrep16756_CR17","doi-asserted-by":"publisher","first-page":"e40385","DOI":"10.1371\/journal.pone.0040385","volume":"7","author":"MD Dicks","year":"2012","unstructured":"Dicks, M. D. et al. A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity. PLoS One 7, e40385 (2012).","journal-title":"PLoS One"},{"key":"BFsrep16756_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/sj.mt.6300024","volume":"15","author":"SE Hensley","year":"2007","unstructured":"Hensley, S. E. et al. Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector. Mol Ther 15, 393\u2013403 (2007).","journal-title":"Mol Ther"},{"key":"BFsrep16756_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1042\/BJ20100766","volume":"431","author":"K Hall","year":"2010","unstructured":"Hall, K., Blair Zajdel, M. E. & Blair, G. E. Unity and diversity in the human adenoviruses: exploiting alternative entry pathways for gene therapy. The Biochemical journal 431, 321\u2013336 (2010).","journal-title":"The Biochemical journal"},{"key":"BFsrep16756_CR20","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.3390\/v2102290","volume":"2","author":"L Coughlan","year":"2010","unstructured":"Coughlan, L. et al. Tropism-modification strategies for targeted gene delivery using adenoviral vectors. Viruses 2, 2290\u20132355 (2010).","journal-title":"Viruses"},{"key":"BFsrep16756_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1099\/0022-1317-83-1-151","volume":"83","author":"CJ Cohen","year":"2002","unstructured":"Cohen, C. J. et al. Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor. J Gen Virol 83, 151\u2013155 (2002).","journal-title":"J Gen Virol"},{"key":"BFsrep16756_CR22","doi-asserted-by":"crossref","first-page":"7909","DOI":"10.1128\/JVI.72.10.7909-7915.1998","volume":"72","author":"PW Roelvink","year":"1998","unstructured":"Roelvink, P. W. et al. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E and F. J Virol 72, 7909\u20137915 (1998).","journal-title":"J Virol"},{"key":"BFsrep16756_CR23","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1073\/pnas.94.7.3352","volume":"94","author":"RP Tomko","year":"1997","unstructured":"Tomko, R. P., Xu, R. & Philipson, L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proceedings of the National Academy of Sciences of the United States of America 94, 3352\u20133356 (1997).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep16756_CR24","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","volume":"275","author":"JM Bergelson","year":"1997","unstructured":"Bergelson, J. M. et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320\u20131323 (1997).","journal-title":"Science"},{"key":"BFsrep16756_CR25","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/nm952","volume":"9","author":"A Gaggar","year":"2003","unstructured":"Gaggar, A., Shayakhmetov, D. M. & Lieber, A. CD46 is a cellular receptor for group B adenoviruses. Nat Med 9, 1408\u20131412 (2003).","journal-title":"Nat Med"},{"key":"BFsrep16756_CR26","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1128\/jvi.69.4.2257-2263.1995","volume":"69","author":"S Huang","year":"1995","unstructured":"Huang, S., Endo, R. I. & Nemerow, G. R. Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J Virol 69, 2257\u20132263 (1995).","journal-title":"J Virol"},{"key":"BFsrep16756_CR27","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1128\/MMBR.63.3.725-734.1999","volume":"63","author":"GR Nemerow","year":"1999","unstructured":"Nemerow, G. R. & Stewart, P. L. Role of alpha(v) integrins in adenovirus cell entry and gene delivery. Microbiology and molecular biology reviews: MMBR 63, 725\u2013734 (1999).","journal-title":"Microbiology and molecular biology reviews: MMBR"},{"key":"BFsrep16756_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","volume":"73","author":"TJ Wickham","year":"1993","unstructured":"Wickham, T. J., Mathias, P., Cheresh, D. A. & Nemerow, G. R. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73, 309\u2013319 (1993).","journal-title":"Cell"},{"key":"BFsrep16756_CR29","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.4049\/jimmunol.1000338","volume":"185","author":"RW Lindsay","year":"2010","unstructured":"Lindsay, R. W. et al. CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling. Journal of immunology 185, 1513\u20131521 (2010).","journal-title":"Journal of immunology"},{"key":"BFsrep16756_CR30","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.4049\/jimmunol.166.8.4809","volume":"166","author":"SA Prasad","year":"2001","unstructured":"Prasad, S. A., Norbury, C. C., Chen, W., Bennink, J. R. & Yewdell, J. W. Cutting edge: recombinant adenoviruses induce CD8 T cell responses to an inserted protein whose expression is limited to nonimmune cells. Journal of immunology 166, 4809\u20134812 (2001).","journal-title":"Journal of immunology"},{"key":"BFsrep16756_CR31","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1182\/blood-2007-02-062117","volume":"110","author":"N Tatsis","year":"2007","unstructured":"Tatsis, N. et al. Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. Blood 110, 1916\u20131923 (2007).","journal-title":"Blood"},{"key":"BFsrep16756_CR32","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1093\/nar\/gni035","volume":"33","author":"S Warming","year":"2005","unstructured":"Warming, S., Costantino, N., Court, D. L., Jenkins, N. A. & Copeland, N. G. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 33, e36 (2005).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep16756_CR33","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1128\/jvi.68.8.5239-5246.1994","volume":"68","author":"LJ Henry","year":"1994","unstructured":"Henry, L. J., Xia, D., Wilke, M. E., Deisenhofer, J. & Gerard, R. D. Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli. J Virol 68, 5239\u20135246 (1994).","journal-title":"J Virol"},{"key":"BFsrep16756_CR34","doi-asserted-by":"publisher","first-page":"12322","DOI":"10.1128\/JVI.01608-12","volume":"86","author":"C Cao","year":"2012","unstructured":"Cao, C. et al. Conserved fiber-penton base interaction revealed by nearly atomic resolution cryo-electron microscopy of the structure of adenovirus provides insight into receptor interaction. J Virol 86, 12322\u201312329 (2012).","journal-title":"J Virol"},{"key":"BFsrep16756_CR35","doi-asserted-by":"publisher","first-page":"10274","DOI":"10.1128\/JVI.74.22.10274-10286.2000","volume":"74","author":"DM Shayakhmetov","year":"2000","unstructured":"Shayakhmetov, D. M. & Lieber, A. Dependence of adenovirus infectivity on length of the fiber shaft domain. J Virol 74, 10274\u201310286 (2000).","journal-title":"J Virol"},{"key":"BFsrep16756_CR36","doi-asserted-by":"publisher","first-page":"e1000503","DOI":"10.1371\/journal.ppat.1000503","volume":"5","author":"S Roy","year":"2009","unstructured":"Roy, S. et al. Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primates. PLoS Pathog 5, e1000503 (2009).","journal-title":"PLoS Pathog"},{"key":"BFsrep16756_CR37","doi-asserted-by":"publisher","first-page":"7225","DOI":"10.1128\/JVI.77.13.7225-7235.2003","volume":"77","author":"E Wu","year":"2003","unstructured":"Wu, E. et al. Flexibility of the adenovirus fiber is required for efficient receptor interaction. J Virol 77, 7225\u20137235 (2003).","journal-title":"J Virol"},{"key":"BFsrep16756_CR38","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0022-2836(05)80170-6","volume":"215","author":"RW Ruigrok","year":"1990","unstructured":"Ruigrok, R. W., Barge, A., Albiges-Rizo, C. & Dayan, S. Structure of adenovirus fibre. II. Morphology of single fibres. Journal of molecular biology 215, 589\u2013596 (1990).","journal-title":"Journal of molecular biology"},{"key":"BFsrep16756_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.molcel.2004.11.041","volume":"17","author":"C Zubieta","year":"2005","unstructured":"Zubieta, C., Schoehn, G., Chroboczek, J. & Cusack, S. The structure of the human adenovirus 2 penton. Molecular cell 17, 121\u2013135 (2005).","journal-title":"Molecular cell"},{"key":"BFsrep16756_CR40","doi-asserted-by":"publisher","first-page":"8270","DOI":"10.1128\/JVI.00048-07","volume":"81","author":"I Madisch","year":"2007","unstructured":"Madisch, I. et al. Phylogenetic analysis and structural predictions of human adenovirus penton proteins as a basis for tissue-specific adenovirus vector design. J Virol 81, 8270\u20138281 (2007).","journal-title":"J Virol"},{"key":"BFsrep16756_CR41","doi-asserted-by":"publisher","first-page":"6416","DOI":"10.1128\/JVI.00445-09","volume":"83","author":"L Coughlan","year":"2009","unstructured":"Coughlan, L. et al. In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery. J Virol 83, 6416\u20136428 (2009).","journal-title":"J Virol"},{"key":"BFsrep16756_CR42","doi-asserted-by":"crossref","first-page":"9508","DOI":"10.1128\/JVI.73.11.9508-9514.1999","volume":"73","author":"I Kirby","year":"1999","unstructured":"Kirby, I. et al. Mutations in the DG loop of adenovirus type 5 fiber knob protein abolish high-affinity binding to its cellular receptor CAR. J Virol 73, 9508\u20139514 (1999).","journal-title":"J Virol"},{"key":"BFsrep16756_CR43","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1182\/blood-2010-03-272336","volume":"117","author":"JD Bassett","year":"2011","unstructured":"Bassett, J. D. et al. CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells. Blood 117, 1146\u20131155 (2011).","journal-title":"Blood"},{"key":"BFsrep16756_CR44","doi-asserted-by":"publisher","first-page":"12027","DOI":"10.1128\/JVI.00593-09","volume":"83","author":"JD Finn","year":"2009","unstructured":"Finn, J. D. et al. Persistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirus. J Virol 83, 12027\u201312036 (2009).","journal-title":"J Virol"},{"key":"BFsrep16756_CR45","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/eji.200425530","volume":"35","author":"P Castiglioni","year":"2005","unstructured":"Castiglioni, P., Gerloni, M., Cortez-Gonzalez, X. & Zanetti, M. CD8 T cell priming by B lymphocytes is CD4 help dependent. European journal of immunology 35, 1360\u20131370 (2005).","journal-title":"European journal of immunology"},{"key":"BFsrep16756_CR46","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jconrel.2012.05.025","volume":"164","author":"AC Bradshaw","year":"2012","unstructured":"Bradshaw, A. C. et al. Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses. Journal of controlled release: official journal of the Controlled Release Society 164, 394\u2013402 (2012).","journal-title":"Journal of controlled release: official journal of the Controlled Release Society"},{"key":"BFsrep16756_CR47","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1182\/blood-2009-12-260026","volume":"116","author":"R Alba","year":"2010","unstructured":"Alba, R. et al. Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors. Blood 116, 2656\u20132664 (2010).","journal-title":"Blood"},{"key":"BFsrep16756_CR48","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1038\/mt.2012.162","volume":"20","author":"L Coughlan","year":"2012","unstructured":"Coughlan, L. et al. Ad5:Ad48 hexon hypervariable region substitutions lead to toxicity and increased inflammatory responses following intravenous delivery. Mol Ther 20, 2268\u20132281 (2012).","journal-title":"Mol Ther"},{"key":"BFsrep16756_CR49","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1371\/journal.ppat.0030025","volume":"3","author":"C Cheng","year":"2007","unstructured":"Cheng, C. et al. Mechanism of ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells. PLoS Pathog 3, e25 (2007).","journal-title":"PLoS Pathog"},{"key":"BFsrep16756_CR50","doi-asserted-by":"publisher","first-page":"14161","DOI":"10.1128\/JVI.79.22.14161-14168.2005","volume":"79","author":"A Nanda","year":"2005","unstructured":"Nanda, A. et al. Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys. J Virol 79, 14161\u201314168 (2005).","journal-title":"J Virol"},{"key":"BFsrep16756_CR51","doi-asserted-by":"publisher","first-page":"9590","DOI":"10.1128\/JVI.00740-12","volume":"86","author":"JE Teigler","year":"2012","unstructured":"Teigler, J. E., Iampietro, M. J. & Barouch, D. H. Vaccination with Adenovirus Serotypes 35, 26 and 48 Elicits Greater Innate Cytokine Responses Than Adenovirus Serotype 5 in Rhesus Monkeys. J Virol 86, 9590\u20139598 (2012).","journal-title":"J Virol"},{"key":"BFsrep16756_CR52","doi-asserted-by":"publisher","first-page":"10634","DOI":"10.1128\/JVI.01359-06","volume":"80","author":"JW Schoggins","year":"2006","unstructured":"Schoggins, J. W. & Falck-Pedersen, E. Fiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity. J Virol 80, 10634\u201310644 (2006).","journal-title":"J Virol"},{"key":"BFsrep16756_CR53","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.immuni.2009.04.015","volume":"31","author":"NC Di Paolo","year":"2009","unstructured":"Di Paolo, N. C. et al. Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo. Immunity 31, 110\u2013121 (2009).","journal-title":"Immunity"},{"key":"BFsrep16756_CR54","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/gt.2013.44","volume":"20","author":"AL Parker","year":"2013","unstructured":"Parker, A. L. et al. Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction. Gene therapy 20, 1158\u20131164 (2013).","journal-title":"Gene therapy"},{"key":"BFsrep16756_CR55","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.4049\/jimmunol.179.3.1721","volume":"179","author":"K Lore","year":"2007","unstructured":"Lore, K. et al. Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses. Journal of immunology 179, 1721\u20131729 (2007).","journal-title":"Journal of immunology"},{"key":"BFsrep16756_CR56","doi-asserted-by":"publisher","first-page":"15191","DOI":"10.1073\/pnas.261452898","volume":"98","author":"CJ Cohen","year":"2001","unstructured":"Cohen, C. J. et al. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proceedings of the National Academy of Sciences of the United States of America 98, 15191\u201315196 (2001).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep16756_CR57","doi-asserted-by":"publisher","first-page":"10862","DOI":"10.1128\/JVI.00928-12","volume":"86","author":"H Li","year":"2012","unstructured":"Li, H. et al. Adenovirus Serotype 26 Utilizes CD46 as a Primary Cellular Receptor and Only Transiently Activates T Lymphocytes Following Vaccination of Rhesus Monkeys. J Virol 86, 10862\u201310865 (2012).","journal-title":"J Virol"},{"key":"BFsrep16756_CR58","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1128\/JVI.78.8.3897-3905.2004","volume":"78","author":"E Wu","year":"2004","unstructured":"Wu, E. et al. Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. J Virol 78, 3897\u20133905 (2004).","journal-title":"J Virol"},{"key":"BFsrep16756_CR59","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1128\/JVI.74.1.42-48.2000","volume":"74","author":"N Arnberg","year":"2000","unstructured":"Arnberg, N., Edlund, K., Kidd, A. H. & Wadell, G. Adenovirus type 37 uses sialic acid as a cellular receptor. J Virol 74, 42\u201348 (2000).","journal-title":"J Virol"},{"key":"BFsrep16756_CR60","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1089\/hum.2011.218","volume":"23","author":"L Coughlan","year":"2012","unstructured":"Coughlan, L. et al. Combined fiber modifications both to target alpha(v)beta(6) and detarget the coxsackievirus-adenovirus receptor improve virus toxicity profiles in vivo but fail to improve antitumoral efficacy relative to adenovirus serotype 5. Human gene therapy 23, 960\u2013979 (2012).","journal-title":"Human gene therapy"},{"key":"BFsrep16756_CR61","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s007050050162","volume":"142","author":"QG Li","year":"1997","unstructured":"Li, Q. G., Lindman, K. & Wadell, G. Hydropathic characteristics of adenovirus hexons. Archives of virology 142, 1307\u20131322 (1997).","journal-title":"Archives of virology"},{"key":"BFsrep16756_CR62","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1128\/JVI.05760-11","volume":"86","author":"R Khare","year":"2012","unstructured":"Khare, R., Reddy, V. S., Nemerow, G. R. & Barry, M. A. Identification of adenovirus serotype 5 hexon regions that interact with scavenger receptors. J Virol 86, 2293\u20132301 (2012).","journal-title":"J Virol"},{"key":"BFsrep16756_CR63","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","volume":"132","author":"SN Waddington","year":"2008","unstructured":"Waddington, S. N. et al. Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132, 397\u2013409 (2008).","journal-title":"Cell"},{"key":"BFsrep16756_CR64","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1182\/blood-2006-04-008532","volume":"108","author":"AL Parker","year":"2006","unstructured":"Parker, A. L. et al. Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood 108, 2554\u20132561 (2006).","journal-title":"Blood"},{"key":"BFsrep16756_CR65","doi-asserted-by":"publisher","first-page":"e1001142","DOI":"10.1371\/journal.ppat.1001142","volume":"6","author":"AC Bradshaw","year":"2010","unstructured":"Bradshaw, A. C. et al. Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X. PLoS Pathog 6, e1001142 (2010).","journal-title":"PLoS Pathog"},{"key":"BFsrep16756_CR66","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/gt.2011.87","volume":"19","author":"R Alba","year":"2012","unstructured":"Alba, R. et al. Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus). Gene therapy 19, 109\u2013113 (2012).","journal-title":"Gene therapy"},{"key":"BFsrep16756_CR67","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nm.3107","volume":"19","author":"Z Xu","year":"2013","unstructured":"Xu, Z. et al. Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement. Nat Med 19, 452\u2013457 (2013).","journal-title":"Nat Med"},{"key":"BFsrep16756_CR68","doi-asserted-by":"publisher","first-page":"e1004673","DOI":"10.1371\/journal.ppat.1004673","volume":"11","author":"J Ma","year":"2015","unstructured":"Ma, J. et al. Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo. PLoS Pathog 11, e1004673 (2015).","journal-title":"PLoS Pathog"},{"key":"BFsrep16756_CR69","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s001090050236","volume":"76","author":"G Acsadi","year":"1998","unstructured":"Acsadi, G. et al. Interferons impair early transgene expression by adenovirus-mediated gene transfer in muscle cells. Journal of molecular medicine 76, 442\u2013450 (1998).","journal-title":"Journal of molecular medicine"},{"key":"BFsrep16756_CR70","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.vaccine.2013.11.055","volume":"32","author":"MJ Johnson","year":"2014","unstructured":"Johnson, M. J. et al. Type I interferon-dependent activation of NK cells by rAd28 or rAd35, but not rAd5, leads to loss of vector-insert expression. Vaccine 32, 717\u2013724 (2014).","journal-title":"Vaccine"},{"key":"BFsrep16756_CR71","doi-asserted-by":"publisher","first-page":"e1638","DOI":"10.1371\/journal.pone.0001638","volume":"3","author":"MG Cottingham","year":"2008","unstructured":"Cottingham, M. G. et al. Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA). PLoS One 3, e1638 (2008).","journal-title":"PLoS One"},{"key":"BFsrep16756_CR72","doi-asserted-by":"publisher","first-page":"19ra12","DOI":"10.1126\/scitranslmed.3000490","volume":"2","author":"R Alcock","year":"2010","unstructured":"Alcock, R. et al. Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass. Science translational medicine 2, 19ra12 (2010).","journal-title":"Science translational medicine"},{"key":"BFsrep16756_CR73","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1016\/j.vaccine.2009.07.025","volume":"27","author":"KC Larsen","year":"2009","unstructured":"Larsen, K. C. et al. Expression of tak1 and tram induces synergistic pro-inflammatory signalling and adjuvants DNA vaccines. Vaccine 27, 5589\u20135598 (2009).","journal-title":"Vaccine"},{"key":"BFsrep16756_CR74","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/gt.2008.177","volume":"16","author":"MP Limberis","year":"2009","unstructured":"Limberis, M. P., Bell, C. L. & Wilson, J. M. Identification of the murine firefly luciferase-specific CD8 T-cell epitopes. Gene therapy 16, 441\u2013447 (2009).","journal-title":"Gene therapy"},{"key":"BFsrep16756_CR75","doi-asserted-by":"publisher","first-page":"e20977","DOI":"10.1371\/journal.pone.0020977","volume":"6","author":"S Biswas","year":"2011","unstructured":"Biswas, S. et al. Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1. PLoS One 6, e20977 (2011).","journal-title":"PLoS One"},{"key":"BFsrep16756_CR76","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nm.1850","volume":"14","author":"SJ Draper","year":"2008","unstructured":"Draper, S. J. et al. Effective induction of high-titer antibodies by viral vector vaccines. Nat Med 14, 819\u2013821 (2008).","journal-title":"Nat Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep16756.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep16756","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep16756.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T19:05:43Z","timestamp":1672945543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep16756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,18]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,22]]}},"alternative-id":["BFsrep16756"],"URL":"https:\/\/doi.org\/10.1038\/srep16756","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,18]]},"assertion":[{"value":"1 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MDJD, SCG, AVSH and MGC are named inventors on a patent application describing the ChAdOx1 vector (US2015044766).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16756"}}